Literature DB >> 15754359

The 22q11.2 deletion in African-American patients: an underdiagnosed population?

Donna M McDonald-McGinn1, Nancy Minugh-Purvis, Richard E Kirschner, Abbas Jawad, Melissa K Tonnesen, Jason R Catanzaro, Elizabeth Goldmuntz, Deborah Driscoll, Don Larossa, Beverly S Emanuel, Elaine H Zackai.   

Abstract

Findings associated with the 22q11.2 deletion often include congenital heart malformations, palatal anomalies, immunodeficiency, hypocalcemia, and developmental delay or learning disabilities. Often the clinical suspicion of the diagnosis in a patient with one or more of these findings is heightened based on the presence of a characteristic facial appearance. In our large cohort of 370 patients with the 22q11.2 deletion, we report the under-representation of African-Americans in our group, as well as, the paucity of craniofacial dysmorphism in these patients. We note that the absence of the typical facial features may result in decreased ascertainment in this population and, furthermore, may delay the implementation of palliative care, cognitive remediation, and recurrence risk counseling. We, therefore, suggest that the clinician's threshold of suspicion should be lower in African-American patients.

Entities:  

Mesh:

Year:  2005        PMID: 15754359      PMCID: PMC2810968          DOI: 10.1002/ajmg.a.30069

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

1.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.

Authors:  D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  Growth hormone deficiency in patients with 22q11.2 deletion: expanding the phenotype.

Authors:  S A Weinzimer; D M McDonald-McGinn; D A Driscoll; B S Emanuel; E H Zackai; T Moshang
Journal:  Pediatrics       Date:  1998-05       Impact factor: 7.124

3.  Normal values for selected physical parameters: an aid to syndrome delineation.

Authors:  M Feingold; W H Bossert
Journal:  Birth Defects Orig Artic Ser       Date:  1974

4.  Velo-cardio-facial and DiGeorge syndromes with meningomyelocele and deletions of the 22Q11 region.

Authors:  R E Nickel; D A Pillers; M Merkens; R E Magenis; D A Driscoll; B S Emanuel; J Zonana
Journal:  Eur J Pediatr Surg       Date:  1993-12       Impact factor: 2.191

5.  NCHS growth curves for children birth-18 years. United States.

Authors:  P V Hamill; T A Drizd; C L Johnson; R B Reed; A F Roche
Journal:  Vital Health Stat 11       Date:  1977-11

6.  Conotruncal anomaly face syndrome is associated with a deletion within chromosome 22q11.

Authors:  J Burn; A Takao; D Wilson; I Cross; K Momma; R Wadey; P Scambler; J Goodship
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

7.  Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.

Authors:  D A Driscoll; J Salvin; B Sellinger; M L Budarf; D M McDonald-McGinn; E H Zackai; B S Emanuel
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

8.  Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.

Authors:  D A Driscoll; N B Spinner; M L Budarf; D M McDonald-McGinn; E H Zackai; R B Goldberg; R J Shprintzen; H M Saal; J Zonana; M C Jones
Journal:  Am J Med Genet       Date:  1992-09-15

9.  Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects.

Authors:  E Goldmuntz; D Driscoll; M L Budarf; E H Zackai; D M McDonald-McGinn; J A Biegel; B S Emanuel
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

10.  Phenotypic differerencss in African Americans with Prader-Willi syndrome.

Authors:  L Hudgins; J S Geer; S B Cassidy
Journal:  Genet Med       Date:  1998 Nov-Dec       Impact factor: 8.822

View more
  17 in total

1.  Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.

Authors:  S X Tang; J J Yi; M E Calkins; D A Whinna; C G Kohler; M C Souders; D M McDonald-McGinn; E H Zackai; B S Emanuel; R C Gur; R E Gur
Journal:  Psychol Med       Date:  2013-09-09       Impact factor: 7.723

2.  Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome.

Authors:  Catherine L Clelland; Laura L Read; Amanda N Baraldi; Corinne P Bart; Carrie A Pappas; Laura J Panek; Robert H Nadrich; James D Clelland
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

3.  22q11.2 deletion syndrome in diverse populations.

Authors:  Paul Kruszka; Yonit A Addissie; Daniel E McGinn; Antonio R Porras; Elijah Biggs; Matthew Share; T Blaine Crowley; Brian H Y Chung; Gary T K Mok; Christopher C Y Mak; Premala Muthukumarasamy; Meow-Keong Thong; Nirmala D Sirisena; Vajira H W Dissanayake; C Sampath Paththinige; L B Lahiru Prabodha; Rupesh Mishra; Vorasuk Shotelersuk; Ekanem Nsikak Ekure; Ogochukwu Jidechukwu Sokunbi; Nnenna Kalu; Carlos R Ferreira; Jordann-Mishael Duncan; Siddaramappa Jagdish Patil; Kelly L Jones; Julie D Kaplan; Omar A Abdul-Rahman; Annette Uwineza; Leon Mutesa; Angélica Moresco; María Gabriela Obregon; Antonio Richieri-Costa; Vera L Gil-da-Silva-Lopes; Adebowale A Adeyemo; Marshall Summar; Elaine H Zackai; Donna M McDonald-McGinn; Marius George Linguraru; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2017-04       Impact factor: 2.802

4.  The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.

Authors:  Sunny X Tang; Tyler M Moore; Monica E Calkins; James J Yi; Adam Savitt; Christian G Kohler; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Ruben C Gur; Raquel E Gur
Journal:  Biol Psychiatry       Date:  2016-09-08       Impact factor: 13.382

Review 5.  Developmental trajectories in 22q11.2 deletion.

Authors:  Ann Swillen; Donna McDonald-McGinn
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-05-18       Impact factor: 3.908

6.  Clinical Features to Predict 22q11.2 Deletion Syndrome Proven by Molecular Genetic Testing.

Authors:  Kitiwan Rojnueangit; Thanitchet Khetkham; Preyaporn Onsod; Takol Chareonsirisuthigul
Journal:  J Pediatr Genet       Date:  2020-10-01

Review 7.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

8.  A comprehensive clinical and genetic study in 127 patients with ID in Kinshasa, DR Congo.

Authors:  Aimé Lumaka; Valerie Race; Hilde Peeters; Anniek Corveleyn; Zeynep Coban-Akdemir; Shalini N Jhangiani; Xiaofei Song; Gerrye Mubungu; Jennifer Posey; James R Lupski; Joris R Vermeesch; Prosper Lukusa; Koenraad Devriendt
Journal:  Am J Med Genet A       Date:  2018-08-08       Impact factor: 2.802

9.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

10.  Sclerocornea associated with the chromosome 22q11.2 deletion syndrome.

Authors:  Gil Binenbaum; Donna M McDonald-McGinn; Elaine H Zackai; B Michael Walker; Karlene Coleman; Amy M Mach; Margaret Adam; Melanie Manning; Deborah M Alcorn; Carrie Zabel; Dennis R Anderson; Brian J Forbes
Journal:  Am J Med Genet A       Date:  2008-04-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.